Medifast, Inc.
NYSE:MEDPersonal Products & Services
Consumer Cyclical
$12.20 -0.04%
-$0.01 today
- Market cap
- $136.43M
- Beta
- 0.66
- P/E (TTM)
- -6.2
- EPS (TTM)
- -$1.82
52W Low $9.22High $15.46
Volume 0.09M
Average 0.21M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$6.86M
FY 2025 · Annual
-72.0% YoYInvesting Cash Flow
-$7.93M
FY 2025 · Annual
Financing Cash Flow
-$564,000.00
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 164.03M | 143.57M | 99.42M | 2.09M | (18.67M) |
| Depreciation & Amortization | 6.81M | 10.98M | 13.11M | 17.4M | 14.24M |
| Deferred Income Tax | (3.72M) | (924K) | 1.21M | (7.4M) | 11.46M |
| Stock-Based Compensation | 9.9M | 11.05M | 8.19M | 7.36M | 7.64M |
| Change in Working Capital | (87.65M) | 21.65M | 20.28M | (9.75M) | (9.81M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | (126.65M) | 61.19M | 64.27M | 12.17M | 22.19M |
| Accounts Payables | 54.38M | (37.59M) | (35.71M) | (34.99M) | (23.91M) |
| Other Working Capital | 39.01M | (1.94M) | (8.28M) | 13.08M | (8.09M) |
| Other Non-Cash Items | 5.16M | 8.24M | 5.46M | 14.77M | 2M |
| Operating Cash Flow | 94.55M | 194.57M | 147.66M | 24.48M | 6.86M |
| Capital Expenditures | (34.21M) | (16.68M) | (6.48M) | (7.45M) | (5.61M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | (54.56M) | (46.6M) | (84.41M) |
| Sales of Investments | 5.15M | 5.27M | 0 | 27.43M | 78.78M |
| Other Investing Activities | 0 | 0 | 0 | 95K | 3.31M |
| Investing Cash Flow | (29.06M) | (11.41M) | (61.05M) | (26.52M) | (7.93M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (62.09M) | (127.96M) | (6.96M) | (836K) | (369K) |
| Dividends Paid | (63.86M) | (71.62M) | (73.02M) | (715K) | (195K) |
| Other Financing Activities | 811K | 0 | 188K | 36K | 0 |
| Financing Cash Flow | (125.13M) | (199.58M) | (79.79M) | (1.52M) | (564K) |
| Effect of Forex Changes | 112K | (67K) | (72K) | 47K | 4K |
| Net Change in Cash | (59.54M) | (16.49M) | 6.75M | (3.51M) | (1.63M) |
| Free Cash Flow | 60.34M | 177.89M | 141.17M | 17.02M | 1.25M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$18.7M
+ D&A$14.2M
+ Stock-Based Comp$7.6M
+ Deferred Tax$11.5M
- Working Capital-$9.8M
+ Other Non-Cash$2.0M
= Operating Cash Flow$6.9M
- Capex-$5.6M
= Free Cash Flow$1.2M
Analysis
FY2025 free cash flow is $1.2M. FCF conversion is -6.7% of net income. Operating cash flow was $6.9M, with capex of -$5.6M. The largest bridge item is D&A at $14.2M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 30, 2026 | |
| 10-Q | Quarterly report | Oct 26, 2026 | |
| 8-K | Current report | Oct 26, 2026 | |
| 4 | Statement of changes in beneficial ownership | Sep 30, 2026 |
Does MED generate free cash flow?
Medifast, Inc. (MED) generated $1.25M of free cash flow in fiscal 2025.
How much operating cash flow does MED produce?
Operating cash flow was $6.86M, before capital expenditures of $5.61M.
Continue the stock analysis
Jump to another research area for this company.